Koa Shoji Holdings (9273) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
6 Nov, 2026Executive summary
Q1 FY2027 net sales fell 3.0% YoY to ¥5,771 million; operating profit declined 17.7% to ¥1,113 million, with results within forecast.
First-quarter progress was broadly in line with expectations; full-year sales and profit are expected to be concentrated in Q4, partly reflecting Zao Factory 2’s scheduled March start.
Financial highlights
Gross profit was ¥1,769 million, down 8.0% YoY; SG&A rose 14.9% to ¥656 million.
Profit attributable to owners of parent fell 12.8% to ¥777 million; comprehensive income was ¥703 million versus ¥901 million YoY.
Foreign-exchange effects added ¥38 million to ordinary profit through non-operating profit/loss.
Outlook and guidance
FY2027 forecasts: net sales ¥26,700 million, up 8.2%; operating profit ¥5,270 million, down 3.8%; ordinary profit ¥5,260 million, down 4.7%; and parent-attributable profit ¥3,590 million, down 4.2%.
Forecast basic EPS is ¥85.24; earnings forecasts were unchanged from the latest announcement.
Latest events from Koa Shoji Holdings
- Record FY2023 results; FY2024 growth forecast with stepped-up investment.9273
Q4 2023 - ROE and PBR remain robust as growth, dividends, and facility investments drive long-term value.9273
Investor presentation - Record sales and profit driven by API growth; Zao Factory 2 to expand syringe output.9273
Q4 2026 - Record FY24 results and a ¥6,500m factory investment support the FY30 ¥8bn profit target.9273
Q4 2024 - API weakness cut sales, while pharmaceutical growth helped lift attributable profit.9273
Q1 2025 - H1 sales and profits grew, with FY2025 guidance maintained.9273
Q2 2025 - Sales and profit rose year-over-year, with operating margin and dividend forecast both increased.9273
Q3 2025 - Record sales and profit growth, with major facility investments supporting future expansion.9273
Q4 2025 - API-driven growth boosted sales and profits, with positive outlook and rising dividends.9273
Q1 2026